Intersect ENT (XENT) Misses Q3 EPS by 6c

Intersect ENT (NASDAQ: XENT) reported Q3 EPS of ($0.35), $0.06 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $14.2 million versus the consensus estimate of $14.8 million.

For earnings history and earnings-related data on Intersect ENT (XENT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Jefferies Reinstates Talen Energy (TLN) at Hold
• MP Materials seen largely insulated after China export-control move